Key Insights

Highlights

Treatment Research

2 treatments under study, led by Bloodsampling

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT06257004Unknown

Genome-wide Epistasis for Cardiovascular Severity in Marfan Study

Showing all 1 trials

Research Network

Common Treatments

  • Bloodsampling1
  • Saliva Collection Screening Of All Participants1

Active Sponsors

  • University Hospital, Ghent1
  • University Hospital, Antwerp1

Top Investigators

Related Conditions

  • Marfan Syndrome1

Activity Timeline